RecruitingPhase 3NCT05052541

Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

Sponsor

University of Colorado, Denver

Enrollment

157 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Back Pain Neck Pain

Summary

The overall objectives of this study are to investigate the efficacy of extended cannabis treatment to reduce patient exposure to prescription opioids through its use 1) as a non-opioid analgesic treatment, and 2) as a therapy for reducing high-dose opioid use in patients with chronic spine pain.

Eligibility

Min Age: 21 YearsMax Age: 84 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo, a drug called THC, and others for people with back pain and neck pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 84 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.